Home/Filings/4/0001104659-21-095507
4//SEC Filing

deGoa Damian 4

Accession 0001104659-21-095507

CIK 0001819576other

Filed

Jul 22, 8:00 PM ET

Accepted

Jul 23, 6:11 PM ET

Size

5.7 KB

Accession

0001104659-21-095507

Insider Transaction Report

Form 4
Period: 2021-07-21
deGoa Damian
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2021-07-21+10,00010,000 total
    Exercise: $2.54Exp: 2031-07-21Common Stock (10,000 underlying)
Footnotes (1)
  • [F1]The option vests over a four-year period with 25% of the shares of common stock underlying the option vesting on the one-year anniversary of the grant date and the remaining 75% of the shares of common stock underlying the option vesting in equal monthly installments thereafter, becoming fully vested on July 21, 2025; provided, however, that notwithstanding the foregoing vesting schedule, 50% of the shares of common sock underlying the option will vest upon U.S. Food and Drug Administration (FDA) tentative approval of the Issuer's New Drug Application for LIQ861.

Issuer

Liquidia Corp

CIK 0001819576

Entity typeother

Related Parties

1
  • filerCIK 0001836165

Filing Metadata

Form type
4
Filed
Jul 22, 8:00 PM ET
Accepted
Jul 23, 6:11 PM ET
Size
5.7 KB